US Saves $313bn From Generics And $2.2bn From Biosimilars

AAM’s Annual Report Focuses On Patient & Stakeholder Benefits

US health insurance
The AAM has released its annual savings report • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Generics

More from Products